One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
LGBTQI Youths Today—New Knowledge, Better Understanding
Martín-J. Sepúlveda, MD, ScD1; Charlotte J. Patterson, PhD2
doi : 10.1001/jamapediatrics.2021.0893
JAMA Pediatr. 2021;175(8):769-770
Origins and Early Management of Medical Child Abuse in Routine Pediatric Care
James C. Hamilton, PhD1,2; John M. Leventhal, MD3; Andrea G. Asnes, MD, MSW3
doi : 10.1001/jamapediatrics.2021.0919
JAMA Pediatr. 2021;175(8):771-772
Use of Probiotics to Prevent Necrotizing Enterocolitis
Abdul Razak, MD1; Ravi Mangal Patel, MD, MSc2; Kanekal Suresh Gautham, MD, MS3
doi : 10.1001/jamapediatrics.2021.1077
JAMA Pediatr. 2021;175(8):773-774
Child Health Inequities Among State Medicaid Programs
Edward L. Schor, MD1; Kay Johnson, MEd, MPH2
doi : 10.1001/jamapediatrics.2021.1082
JAMA Pediatr. 2021;175(8):775-776
Human Milk Fortification for Preterm Infants
Mercedes Pilkington, MD1; Belal N. Alshaikh, MD, MSc2; Mary E. Brindle, MD, MPH1,3
doi : 10.1001/jamapediatrics.2021.0689
JAMA Pediatr. 2021;175(8):777-778
Questioning the Value of High-Deductible Health Plans for Children With Chronic Conditions
Jennifer Kusma, MD, MS1,2,3; Matthew M. Davis, MD, MAPP1,2,3,4,5,6
doi : 10.1001/jamapediatrics.2021.0752
JAMA Pediatr. 2021;175(8):778-781
COVID-19 in Pregnant Women and Their Newborn Infants
C. Mary Healy, MD1
doi : 10.1001/jamapediatrics.2021.1046
JAMA Pediatr. 2021;175(8):781-783
Epidemiology of Multisystem Inflammatory Syndrome in Children
Jennifer A. Blumenthal, MD1,2,3; Jeffrey P. Burns, MD, MPH1,2,3
doi : 10.1001/jamapediatrics.2021.0638
JAMA Pediatr. 2021;175(8):783-785
Early Intervention in Cerebral Palsy and Beyond
Abdellah Tebani, PharmD, PhD1; Stéphane Marret, MD, PhD2
doi : 10.1001/jamapediatrics.2021.0884
JAMA Pediatr. 2021;175(8):785-787
Equity and the JAMA Network
Phil B. Fontanarosa, MD, MBA1; Annette Flanagin, RN, MA2; John Z. Ayanian, MD, MPP3,4; Robert O. Bonow, MD, MS5,6; Neil M. Bressler, MD7,8; Dimitri Christakis, MD, MPH9,10; Mary L. Disis, MD11,12; S. Andrew Josephson, MD13,14; Melina R. Kibbe, MD15,16; Dost Öngür, MD, PhD17,18; Jay F. Piccirillo, MD19,20; Rita F. Redberg, MD, MPH21,22; Frederick P. Rivara, MD, MPH23,24; Kanade Shinkai, MD, PhD25,26; Clyde W. Yancy, MD, MSc27,28
doi : 10.1001/jamapediatrics.2021.2251
JAMA Pediatr. 2021;175(8):787-789
Fortification of Breast Milk With Preterm Formula Powder vs Human Milk Fortifier in Preterm Neonates
Arunambika Chinnappan, MD1; Akash Sharma, DM1; Ramesh Agarwal, DM1; Anu Thukral, DM1; Ashok Deorari, MD1; M. Jeeva Sankar, DM1
doi : 10.1001/jamapediatrics.2021.0678
JAMA Pediatr. 2021;175(8):790-796
Fortification of expressed breast milk (EBM) using commercially available human milk fortifiers (HMF) increases short-term weight and length in preterm very low-birth-weight (VLBW) neonates. However, the high cost and increased risk of feed intolerance limit their widespread use. Preterm formula powder fortification (PTF) might be a better alternative in resource-limited settings.
Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis
Libby Haskell, MN1; Emma J. Tavender, PhD2,3; Catherine L. Wilson, MPH2; Sharon O’Brien, BNurs4,5; Franz E. Babl, MD2,6,7; Meredith L. Borland, MBBS4,8; Elizabeth Cotterell, MPH9,10; Rachel Schembri, PhD11; Francesca Orsini, MSc11; Nicolette Sheridan, PhD12; David W. Johnson, MD13; Ed Oakley, MBBS2,7,14; Stuart R. Dalziel, PhD1,15; for the PREDICT Network
doi : 10.1001/jamapediatrics.2021.0295
JAMA Pediatr. 2021;175(8):797-806
In developed countries, bronchiolitis is the most common reason for infants to be admitted to the hospital, and all international bronchiolitis guidelines recommend supportive care; however, significant variation in practice continues with infants receiving non–evidence-based therapies. Deimplementation research aims to reduce the use of low-value care, and advancing science in this area is critical to delivering evidence-based care.
Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans
Alison A. Galbraith, MD, MPH1,2,3; Dennis Ross-Degnan, ScD1; Fang Zhang, PhD1; Ann Chen Wu, MD, MPH1,2; Anna Sinaiko, PhD4; Alon Peltz, MD, MBA, MHS1,2; Xin Xu, MS1,5; Jamie Wallace, MPH1,6; J. Frank Wharam, MB, BCh, BAO, MPH1
doi : 10.1001/jamapediatrics.2021.0747
JAMA Pediatr. 2021;175(8):807-816
High-deductible health plans (HDHPs) are increasingly common and associated with decreased medication use in some adult populations. How children are affected is less certain.
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
José Villar, MD1,2; Shabina Ariff, MD3; Robert B. Gunier, PhD4; Ramachandran Thiruvengadam, MD5; Stephen Rauch, MPH4; Alexey Kholin, MD6; Paola Roggero, PhD7,8; Federico Prefumo, PhD9,10; Marynéa Silva do Vale, MD11; Jorge Arturo Cardona-Perez, MD12; Nerea Maiz, PhD13; Irene Cetin, MD14; Valeria Savasi, PhD15; Philippe Deruelle, PhD16; Sarah Rae Easter, MD17,18; Joanna Sichitiu, MD19; Constanza P. Soto Conti, MD20; Ernawati Ernawati, PhD21,22; Mohak Mhatre, MD23; Jagjit Singh Teji, MD24; Becky Liu, MBBS25; Carola Capelli, MD26; Manuela Oberto, MD27; Laura Salazar, MD28; Michael G. Gravett, MD29,30; Paolo Ivo Cavoretto, PhD31; Vincent Bizor Nachinab, MD32; Hadiza Galadanci, MSc33,34; Daniel Oros, PhD35; Adejumoke Idowu Ayede, MD36,37; Loïc Sentilhes, PhD38; Babagana Bako, MD39; Mónica Savorani, MD40; Hellas Cena, PhD41,42; Perla K. García-May, MD43; Saturday Etuk, MD44; Roberto Casale, MD45; Sherief Abd-Elsalam, PhD46; Satoru Ikenoue, PhD47; Muhammad Baffah Aminu, MD48; Carmen Vecciarelli, MD49; Eduardo A. Duro, MD50,51; Mustapha Ado Usman, MBBS52; Yetunde John-Akinola, PhD36,37; Ricardo Nieto, MD20; Enrico Ferrazi, MD8; Zulfiqar A. Bhutta, PhD53; Ana Langer, MD54; Stephen H. Kennedy, MD1,2; Aris T. Papageorghiou, MD1,2,25
doi : 10.1001/jamapediatrics.2021.1050
JAMA Pediatr. 2021;175(8):817-826
Detailed information about the association of COVID-19 with outcomes in pregnant individuals compared with not-infected pregnant individuals is much needed.
Computational Methods to Measure Patterns of Gaze in Toddlers With Autism Spectrum Disorder
Zhuoqing Chang, PhD1; J. Matias Di Martino, PhD1; Rachel Aiello, PhD2,3; Jeffrey Baker, MD, PhD4; Kimberly Carpenter, PhD2,3; Scott Compton, PhD2,3; Naomi Davis, PhD2,3; Brian Eichner, MD4; Steven Espinosa, BSc5; Jacqueline Flowers, PhD2,3; Lauren Franz, MBChB, MPH2,3,6; Adrianne Harris, MA3,7; Jill Howard, PhD2,3; Sam Perochon, MS1,8; Eliana M. Perrin, MD, MPH4,9; Pradeep Raj Krishnappa Babu, PhD1; Marina Spanos, PhD2,3; Connor Sullivan, PhD2,3; Barbara K. Walter, PhD, MPH4; Scott H. Kollins, PhD2,3; Geraldine Dawson, PhD2,3,6,10; Guillermo Sapiro, PhD1,3,11
doi : 10.1001/jamapediatrics.2021.0530
JAMA Pediatr. 2021;175(8):827-836
Atypical eye gaze is an early-emerging symptom of autism spectrum disorder (ASD) and holds promise for autism screening. Current eye-tracking methods are expensive and require special equipment and calibration. There is a need for scalable, feasible methods for measuring eye gaze.
Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic
Ermias D. Belay, MD1; Joseph Abrams, PhD1; Matthew E. Oster, MD1; Jennifer Giovanni, PhD1; Timmy Pierce, MPH1,2; Lu Meng, PhD1,3; Emily Prezzato, MPH1; Neha Balachandran, MBBS, MPH1; John J. Openshaw, MD4; Hilary E. Rosen, MPH4; Moon Kim, MD5; Gillian Richardson, MPH6; Julie Hand, MSPH6; Melissa Tobin-D’Angelo, MD7; Siri Wilson, MPH7; Amanda Hartley, BSN, RN8; Cassandra Jones, MPH8; Jonathan Kolsin, MPH9; Hani Mohamed, MD10; Zachary Colles, MPH11; Teresa Hammett, MPH1; Pragna Patel, MD, MPH1; Bryan Stierman, MD1,12; Angela P. Campbell, MD1; Shana Godfred-Cato, DO1
doi : 10.1001/jamapediatrics.2021.0630
JAMA Pediatr. 2021;175(8):837-845
Multiple inflammatory syndrome in children (MIS-C) occurs in association with the COVID-19 pandemic.
Association of Local Variation in Neighborhood Disadvantage in Metropolitan Areas With Youth Neurocognition and Brain Structure
Daniel A. Hackman, PhD1; Dora Cserbik, MS2; Jiu-Chiuan Chen, MD, ScD, MPH2,3; Kiros Berhane, PhD4; Bita Minaravesh, MPH5; Rob McConnell, MD2; Megan M. Herting, PhD2,6
doi : 10.1001/jamapediatrics.2021.0426
JAMA Pediatr. 2021;175(8):e210426
Neighborhood disadvantage is an important social determinant of health in childhood and adolescence. Less is known about the association of neighborhood disadvantage with youth neurocognition and brain structure, and particularly whether associations are similar across metropolitan areas and are attributed to local differences in disadvantage.
Association of Very Preterm Birth or Very Low Birth Weight With Intelligence in Adulthood
Robert Eves, MSc1; Marina Mendonça, PhD1; Nicole Baumann, BSc1; Yanyan Ni, PhD1; Brian A. Darlow, MD2; John Horwood, MSc3; Lianne J. Woodward, PhD4; Lex W. Doyle, MD5,6,7; Jeanie Cheong, MD5,6,7; Peter J. Anderson, PhD7,8; Peter Bartmann, MD, PhD9; Neil Marlow, DM10; Samantha Johnson, PhD11; Eero Kajantie, DMedSc12,13,14,15; Petteri Hovi, MD, PhD12,15; Chiara Nosarti, PhD16,17; Marit S. Indredavik, MD, PhD14; Kari-Anne I. Evensen, PhD14,18,19; Katri Räikkönen, PhD20; Kati Heinonen, PhD20,21; Jennifer Zeitlin, DSc22; Dieter Wolke, PhD, Dr rer nat hc1,23
doi : 10.1001/jamapediatrics.2021.1058
JAMA Pediatr. 2021;175(8):e211058
Birth before 32 weeks’ gestation (very preterm [VPT]) and birth weight below 1500 g (very low birth weight [VLBW]) have been associated with lower cognitive performance in childhood. However, there are few investigations of the association of neonatal morbidities and maternal educational levels with the adult cognitive performance of individuals born VPT or VLBW (VPT/VLBW).
Early Intervention for Children Aged 0 to 2 Years With or at High Risk of Cerebral Palsy
Catherine Morgan, PhD1; Linda Fetters, PhD2; Lars Adde, PhD3,4; Nadia Badawi, PhD1,5; Ada Bancale, NPT6; Roslyn N. Boyd, PhD7; Olena Chorna, CCRP6; Giovanni Cioni, MD6,8; Diane L. Damiano, PhD9; Johanna Darrah, PhD10; Linda S. de Vries, PhD11; Stacey Dusing, PhD2; Christa Einspieler, PhD12; Ann-Christin Eliasson, PhD13; Donna Ferriero, MD14; Darcy Fehlings, MD15; Hans Forssberg, MD16; Andrew M. Gordon, PhD17; Susan Greaves, PhD18; Andrea Guzzetta, PhD6,8; Mijna Hadders-Algra, PhD19; Regina Harbourne, PhD20; Petra Karlsson, PhD1; Lena Krumlinde-Sundholm, PhD13; Beatrice Latal, PhD21; Alison Loughran-Fowlds, PhD5; Catherine Mak, PhD7; Nathalie Maitre, MD22; Sarah McIntyre, PhD1; Cristina Mei, PhD23,24,25; Angela Morgan, PhD18,24,25; Angelina Kakooza-Mwesige, PhD26; Domenico M. Romeo, PhD27; Katherine Sanchez, PhD25; Alicia Spittle, PhD25,28; Roberta Shepherd, PhD29; Marelle Thornton, DipEd1; Jane Valentine, PhD30; Roslyn Ward, PhD31; Koa Whittingham, PhD7; Alieh Zamany, DPT32; Iona Novak, PhD29
doi : 10.1001/jamapediatrics.2021.0878
JAMA Pediatr. 2021;175(8):846-858
Cerebral palsy (CP) is the most common childhood physical disability. Early intervention for children younger than 2 years with or at risk of CP is critical. Now that an evidence-based guideline for early accurate diagnosis of CP exists, there is a need to summarize effective, CP-specific early intervention and conduct new trials that harness plasticity to improve function and increase participation. Our recommendations apply primarily to children at high risk of CP or with a diagnosis of CP, aged 0 to 2 years.
Return to Play After COVID-19 Infection in Children
Lindsay A. Thompson, MD, MS1,2; Maria N. Kelly, MD1
doi : 10.1001/jamapediatrics.2021.1485
JAMA Pediatr. 2021;175(8):875
Children and COVID-19 Vaccines
Lindsay A. Thompson, MD, MS1,2; Sonja A. Rasmussen, MD, MS1,3,4
doi : 10.1001/jamapediatrics.2021.1974
JAMA Pediatr. 2021;175(8):876
Assessing Child Abuse Hotline Inquiries in the Wake of COVID-19
Robin Ortiz, MD1,2; Rachel Kishton, MD1; Laura Sinko, PhD, RN1; Michelle Fingerman, MS3; Diane Moreland, MS4; Joanne Wood, MD, MSHP2; Atheendar Venkataramani, MD, PhD5
doi : 10.1001/jamapediatrics.2021.0525
JAMA Pediatr. 2021;175(8):859-861
Prevalence of Perceived Racism and Discrimination Among US Children Aged 10 and 11 Years
Jason M. Nagata, MD, MSc1; Kyle T. Ganson, PhD, MSW2; Omar M. Sajjad, MS1; Samuel E. Benabou1; Kirsten Bibbins-Domingo, PhD, MD, MAS3
doi : 10.1001/jamapediatrics.2021.1022
JAMA Pediatr. 2021;175(8):861-863
A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California
Abigail S. Friedman, PhD1
doi : 10.1001/jamapediatrics.2021.0922
JAMA Pediatr. 2021;175(8):863-865
Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus
Daniel Blázquez-Gamero, MD, PhD1; Blanca Sánchez, MD2; María Dolores Folgueira, MD, PhD3
doi : 10.1001/jamapediatrics.2021.0755
JAMA Pediatr. 2021;175(8):865-866
Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus—Reply
Mark R. Schleiss, MD1; Mark T. McCann, BA2; Sheila C. Dollard, PhD3
doi : 10.1001/jamapediatrics.2021.0758
JAMA Pediatr. 2021;175(8):866
Research, Practice, and Policy Implications of Adverse Childhood Events
Edward L. Machtinger, MD1; Alicia Lieberman, PhD1; Marguerita Lightfoot, PhD1
doi : 10.1001/jamapediatrics.2021.0810
JAMA Pediatr. 2021;175(8):866-867
Research, Practice, and Policy Implications of Adverse Childhood Events—Reply
Jessie R. Baldwin, PhD1,2; Andrea Danese, MD, PhD2,3,4
doi : 10.1001/jamapediatrics.2021.0813
JAMA Pediatr. 2021;175(8):867-868
Structural Factors, Power, and the Physician Sex Pay Gap
Julia E. Szymczak, PhD1
doi : 10.1001/jamapediatrics.2021.0870
JAMA Pediatr. 2021;175(8):868
Structural Factors, Power, and the Physician Sex Pay Gap—Reply
Terrill Bravender, MD, MPH1; Ellen Selkie, MD, MPH1; Reshma Jagsi, MD, DPhil2
doi : 10.1001/jamapediatrics.2021.0873
JAMA Pediatr. 2021;175(8):868-869
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care
Michiel F. Schreuder, MD, PhD1; Rasmus Ehren, MD2; Lutz T. Weber, MD2
doi : 10.1001/jamapediatrics.2021.1071
JAMA Pediatr. 2021;175(8):869-870
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care
Beatrice Belluzzi, MD1; Benedetta Bossini, MD1; Marco Pennesi, MD2
doi : 10.1001/jamapediatrics.2021.1074
JAMA Pediatr. 2021;175(8):870
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care—Reply
Andrea Angeletti, MD, PhD1; Pietro Ravani, MD2; Gian Marco Ghiggeri, MD1,3
doi : 10.1001/jamapediatrics.2021.1068
JAMA Pediatr. 2021;175(8):870-871
Errors in Introduction and End Matter
doi : 10.1001/jamapediatrics.2021.1946
JAMA Pediatr. 2021;175(8):871
Nonauthor Collaborator Supplement Added
doi : 10.1001/jamapediatrics.2021.2131
JAMA Pediatr. 2021;175(8):871
